These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3591453)

  • 61. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
    Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
    J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarction.
    Sane DC; Stump DC; Topol EJ; Sigmon KN; Kereiakes DJ; George BS; Mantell SJ; Macy E; Collen D; Califf RM
    Thromb Haemost; 1991 Mar; 65(3):275-9. PubMed ID: 1904653
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction.
    Moliterno DJ; Lange RA; Meidell RS; Willard JE; Leffert CC; Gerard RD; Boerwinkle E; Hobbs HH; Hillis LD
    Circulation; 1993 Sep; 88(3):935-40. PubMed ID: 8353920
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
    Glueck CJ; Glueck HI; Stroop D; Speirs J; Hamer T; Tracy T
    J Lab Clin Med; 1993 Oct; 122(4):412-20. PubMed ID: 8228555
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased blood fibrinolytic activity after physical exercise: comparative study in individuals with different sporting activities and in patients after myocardial infarction taking part in a rehabilitation sports program.
    Speiser W; Langer W; Pschaick A; Selmayr E; Ibe B; Nowacki PE; Müller-Berghaus G
    Thromb Res; 1988 Sep; 51(5):543-55. PubMed ID: 3140411
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thrombin generation and fibrinolytic activities among patients receiving reduced-dose alteplase plus abciximab or undergoing direct angioplasty plus abciximab for acute myocardial infarction.
    Mak KH; Lee LH; Wong A; Chan C; Koh TH; Lau KW; Lim YL
    Am J Cardiol; 2002 Apr; 89(8):930-6. PubMed ID: 11950430
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Increased plasminogen activator inhibitor activity in survivors of myocardial infarction is associated with metabolic risk factors of atherosclerosis.
    Keber I; Keber D
    Haemostasis; 1992; 22(4):187-94. PubMed ID: 1468721
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy.
    Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
    Am J Cardiol; 1996 Jul; 78(1):19-25. PubMed ID: 8712112
    [TBL] [Abstract][Full Text] [Related]  

  • 69. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
    Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
    J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Severity of coronary artery disease and basal fibrinolysis.
    Small M; Lowe GD; Beattie JM; Hutton I; Lorimer AR; Forbes CD
    Haemostasis; 1987; 17(5):305-11. PubMed ID: 2444504
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
    Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
    Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tissue plasminogen activator activity and inhibition in acute myocardial infarction and angiographically normal coronary arteries.
    Verheugt FW; ten Cate JW; Sturk A; Imandt L; Verhorst PM; van Eenige MJ; Verwey W; Roos JP
    Am J Cardiol; 1987 May; 59(12):1075-9. PubMed ID: 3107367
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators.
    Vaughan DE; Rouleau JL; Ridker PM; Arnold JM; Menapace FJ; Pfeffer MA
    Circulation; 1997 Jul; 96(2):442-7. PubMed ID: 9244210
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction.
    Thøgersen AM; Söderberg S; Jansson JH; Dahlén G; Boman K; Nilsson TK; Lindahl B; Weinehall L; Stenlund H; Lundberg V; Johnson O; Ahrén B; Hallmans G
    Eur J Cardiovasc Prev Rehabil; 2004 Feb; 11(1):33-40. PubMed ID: 15167204
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP; Hanssen M
    Drugs; 1987; 33 Suppl 3():247-52. PubMed ID: 2445540
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Study of proteolytic systems of the blood in patients with myocardial infarction].
    Lussa A; Bodzenta A; Buluk K
    Pol Tyg Lek; 1988 Apr; 43(16):513-6. PubMed ID: 3412988
    [No Abstract]   [Full Text] [Related]  

  • 78. Biological study of intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Samama M; Conard J; Verdy E; van Dreden P; Nguyen G; Combrisson A; Acar J
    Drugs; 1987; 33 Suppl 3():268-74. PubMed ID: 3315605
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Excessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinase.
    Liebman HA; Carfagno MK; Weitz IC; Berard P; Diiorio JM; Vosburgh E; Simms RW
    Am J Clin Pathol; 1992 Nov; 98(5):534-41. PubMed ID: 1485607
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.
    Strauss BH; Lau HK; Bowman KA; Sparkes J; Chisholm RJ; Garvey MB; Fenkell LL; Natarajan MK; Singh I; Teitel JM
    Circulation; 1999 Oct; 100(15):1616-22. PubMed ID: 10517732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.